Crossmark

Fibroblasts tune myocardial inflammation and remodeling

Crossref DOI link: https://doi.org/10.1038/s44161-022-00119-4

Published Online: 2022-08-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Perez-Shibayama, Christian

Gil-Cruz, Cristina

Ludewig, Burkhard https://orcid.org/0000-0002-7685-573X
License Information

Text and Data Mining valid from 2022-08-12

Version of Record valid from 2022-08-12
More Information

Article History

First Online: 12 August 2022

Competing interests

: C.G.C., C.P.S. and B.L. are co-founders and shareholders of Stromal Therapeutics.